KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Amortizatization of Intangibles (2018 - 2019)

BeOne Medicines (ONC) has disclosed Amortizatization of Intangibles for 2 consecutive years, with -$51000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Amortizatization of Intangibles rose 98.85% to -$51000.0 in Q3 2019 year-over-year; TTM through Sep 2019 was -$7.3 million, a 64.29% decrease, with the full-year FY2018 number at -$8.0 million, changed N/A from a year prior.
  • Amortizatization of Intangibles was -$51000.0 for Q3 2019 at BeOne Medicines, up from -$1.2 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of -$51000.0 in Q3 2019 to a low of -$4.4 million in Q3 2018.